Outset Medical (OM) Cash & Equivalents (2018 - 2026)

Outset Medical (OM) has 9 years of Cash & Equivalents data on file, last reported at $160.5 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $160.5 million, up 111.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $160.5 million (up 111.38% YoY), and the FY2025 annual result was $35.0 million, down 71.77% from the prior year.
• Cash & Equivalents rose to $160.5 million in Q1 2026 per OM's latest filing, from $35.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $187.4 million in Q2 2025 and troughed at $35.0 million in Q4 2025.
• A 5-year average of $81.7 million and a median of $71.8 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents sank 72.47% in 2022, then surged 397.05% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $76.5 million in 2022, then slipped by 6.13% to $71.8 million in 2023, then soared by 72.63% to $124.0 million in 2024, then slumped by 71.77% to $35.0 million in 2025, then surged by 358.49% to $160.5 million in 2026.
• Business Quant data shows OM's Cash & Equivalents at $160.5 million in Q1 2026, $35.0 million in Q4 2025, and $182.0 million in Q3 2025.